The oxidation-induced cross-linking of lipid poor ApoA-I in CAD lesions, reduced cholesterol efflux capacity, and the decline in PON-1 and LCAT activity of the HDL result from MPO enrichment in the atherosclerotic plaques [164,165]. The gene discussed is APOA1; the disease is coronary artery disorder.